CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 146 filers reported holding CLOVIS ONCOLOGY INC in Q4 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,946,000 | -35.6% | 66,266 | -0.4% | 0.00% | -33.3% |
| Q2 2018 | $3,024,000 | -14.4% | 66,510 | -0.6% | 0.00% | -25.0% |
| Q1 2018 | $3,534,000 | -0.4% | 66,937 | +28.3% | 0.00% | 0.0% |
| Q4 2017 | $3,547,000 | -38.9% | 52,155 | -25.9% | 0.00% | -33.3% |
| Q3 2017 | $5,804,000 | +0.6% | 70,432 | +14.3% | 0.01% | 0.0% |
| Q2 2017 | $5,772,000 | +117.7% | 61,646 | +48.1% | 0.01% | +100.0% |
| Q1 2017 | $2,651,000 | +190.0% | 41,629 | +59.3% | 0.00% | +200.0% |
| Q4 2015 | $914,000 | -67.8% | 26,127 | -15.4% | 0.00% | -66.7% |
| Q3 2015 | $2,840,000 | +47.6% | 30,887 | +41.1% | 0.00% | +50.0% |
| Q2 2015 | $1,924,000 | +16.7% | 21,895 | -1.4% | 0.00% | 0.0% |
| Q1 2015 | $1,648,000 | +18.2% | 22,196 | -10.8% | 0.00% | 0.0% |
| Q4 2014 | $1,394,000 | +22.2% | 24,884 | -1.1% | 0.00% | +100.0% |
| Q3 2014 | $1,141,000 | +28.1% | 25,163 | +17.0% | 0.00% | 0.0% |
| Q2 2014 | $891,000 | -26.6% | 21,513 | +22.8% | 0.00% | 0.0% |
| Q1 2014 | $1,214,000 | – | 17,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |